ARCHIVES

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

This article is from The Cancer Letter archive.

Vol. 36 No. 01 | January 15, 2010

Download PDF Visit The Full Archive

Related Articles

FASEB Urges 6.7 Percent Increase In NIH Budget.

February 1, 2008

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Avoiding the Hippocampus During Whole-Brain Radiotherapy Can Preserve Memory Function

September 27, 2013

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

Funding Opportunities: Lymphoma Fellowship

June 8, 2001